Annual EBITDA
-$1.61 M
-$771.00 K-91.90%
01 December 2023
Summary:
Kairos Pharma annual earnings before interest, taxes, depreciation & amortization is currently -$1.61 million, with the most recent change of -$771.00 thousand (-91.90%) on 01 December 2023. During the last 3 years, it has fallen by -$564.00 thousand (-53.92%).KAPA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$880.00 K
-$679.00 K-337.81%
30 September 2024
Summary:
Kairos Pharma quarterly earnings before interest, taxes, depreciation & amortization is currently -$880.00 thousand, with the most recent change of -$679.00 thousand (-337.81%) on 30 September 2024. Over the past year, it has dropped by -$623.00 thousand (-242.41%).KAPA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$2.42 M
-$623.00 K-34.61%
30 September 2024
Summary:
Kairos Pharma TTM earnings before interest, taxes, depreciation & amortization is currently -$2.42 million, with the most recent change of -$623.00 thousand (-34.61%) on 30 September 2024. Over the past year, it has dropped by -$1.74 million (-253.72%).KAPA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KAPA EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -91.9% | -242.4% | -253.7% |
| 3 y3 years | -53.9% | - | - |
| 5 y5 years | - | - | - |
KAPA EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | +91.9% | +816.7% | +1209.7% |
Kairos Pharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$880.00 K(+337.8%) | -$2.42 M(+34.6%) |
| June 2024 | - | -$201.00 K(-24.7%) | -$1.80 M(+1.1%) |
| Mar 2024 | - | -$267.00 K(-75.2%) | -$1.78 M(+10.6%) |
| Dec 2023 | -$1.61 M | -$1.07 M(+318.3%) | -$1.61 M(+135.0%) |
| Sept 2023 | - | -$257.00 K(+41.2%) | -$685.00 K(+13.8%) |
| June 2023 | - | -$182.00 K(+89.6%) | -$602.00 K(-19.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$96.00 K(-36.0%) | -$750.00 K(-10.6%) |
| Dec 2022 | -$839.00 K(-58.6%) | -$150.00 K(-13.8%) | -$839.00 K(+21.8%) |
| Sept 2022 | - | -$174.00 K(-47.3%) | -$689.00 K(+33.8%) |
| June 2022 | - | -$330.00 K(+78.4%) | -$515.00 K(+178.4%) |
| Mar 2022 | - | -$185.00 K | -$185.00 K |
| Dec 2021 | -$2.03 M(+93.8%) | - | - |
| Dec 2020 | -$1.05 M | - | - |
FAQ
- What is Kairos Pharma annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Kairos Pharma?
- What is Kairos Pharma annual EBITDA year-on-year change?
- What is Kairos Pharma quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Kairos Pharma?
- What is Kairos Pharma quarterly EBITDA year-on-year change?
- What is Kairos Pharma TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Kairos Pharma?
- What is Kairos Pharma TTM EBITDA year-on-year change?
What is Kairos Pharma annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of KAPA is -$1.61 M
What is the all time high annual EBITDA for Kairos Pharma?
Kairos Pharma all-time high annual earnings before interest, taxes, depreciation & amortization is -$839.00 K
What is Kairos Pharma annual EBITDA year-on-year change?
Over the past year, KAPA annual earnings before interest, taxes, depreciation & amortization has changed by -$771.00 K (-91.90%)
What is Kairos Pharma quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of KAPA is -$880.00 K
What is the all time high quarterly EBITDA for Kairos Pharma?
Kairos Pharma all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$96.00 K
What is Kairos Pharma quarterly EBITDA year-on-year change?
Over the past year, KAPA quarterly earnings before interest, taxes, depreciation & amortization has changed by -$623.00 K (-242.41%)
What is Kairos Pharma TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of KAPA is -$2.42 M
What is the all time high TTM EBITDA for Kairos Pharma?
Kairos Pharma all-time high TTM earnings before interest, taxes, depreciation & amortization is -$185.00 K
What is Kairos Pharma TTM EBITDA year-on-year change?
Over the past year, KAPA TTM earnings before interest, taxes, depreciation & amortization has changed by -$1.74 M (-253.72%)